Can a 100-Year-Old TB vaccine help fight a tough lung infection?
NCT ID NCT07094711
First seen May 14, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This study is testing whether the BCG vaccine, originally developed for tuberculosis, can be safely used to treat a chronic lung infection called MAC. About 48 adults with MAC lung disease will receive either a BCG injection or a placebo. Researchers will track side effects, immune responses, and changes in sputum cultures over 12 months to see if the vaccine helps control the infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Virginia Health
RECRUITINGCharlottesville, Virginia, 22908, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.